Trial intelligence / Profile preview

HEAT trial of intravenous paracetamol for fever in critically ill patients with known or suspected infection

ACTRN12612000513819Phase 3Completed

Sponsor
Medical Research Institute of New Zealand
Start
Mar 2013
Modality
Small Molecules
Countries
2
01

Overview

Phase 3, randomised, double-blind trial in Infection comparing Paracetamol with Placebo (2 arms). Primary endpoint: Alive ICU-free days to day 28. Started Mar 2013; status: completed.

02

Drugs

acetaminophen
03

Conditions

Infection

Beyond the preview

Go deeper on ACTRN12612000513819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000513819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call